HIV PROTEASE INHIBITING SULFONAMIDES

(19)

(11)

EP 1 709 037 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	17.02.2010 Bulletin 2010/07

(45)	Mention of the grant of the patent:
	23.12.2009 Bulletin 2009/52

(21)	Application number: 04810802.1

(22)	Date of filing: 10.11.2004

(51)

International Patent Classification (IPC):

C07D 417/06^(2006.01)

(86)	International application number:
	PCT/US2004/037745

(87)	International publication number:
	WO 2005/061450 (07.07.2005 Gazette 2005/27)

(54)	HIV PROTEASE INHIBITING SULFONAMIDES DIE HIV-PROTEASE INHIBIERENDE SULFONAMIDE COMPOSES INHIBANT LA PROTEASE DU VIH

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR

(30)

Priority:

11.12.2003 US 733915

(43)	Date of publication of application:
	11.10.2006 Bulletin 2006/41

(60)	Divisional application:
	09176641.0

(73)	Proprietor: ABBOTT LABORATORIES
	Abbott Park, IL 60064-6008 (US)

(72)

Inventors:

FLENTGE, Charles, A.
Salem, Wisconsin 53168 (US)
CHEN, Hui-Ju
Grayslake, Illinois 60030 (US)
DEGOEY, David, A.
Salem, Wisconsin 53168 (US)
FLOSI, William, J.;
Evanston, Illinois 60202 (US)
GRAMPOVNIK, David, J.
Waukegan, Illinois 60087 (US)
HUANG, Peggy, P.
Lake Bluff, Illinois 60044 (US)
KEMPF, Dale, J.
Libertyville, IL 60048 (US)
KLEIN, Larry, L.
Lake Forest, Illinois 60045 (US)
KRUEGER, Allan, C.
Gurnee, Illinois 60031 (US)
MADIGAN, Darold, L.
Elk Grove Village, Illinois 60007 (US)
RANDOLPH, John, T.
Mundelein, , Illinois 60060 (US)
SUN, Minghua
Libertyville, Illinois 60048 (US)
YEUNG, Ming, C.
Grayslake, Illinois 60030 (US)
ZHAO, Chen
Libertyville, Illinois 60048 (US)

(74)	Representative: Modiano, Micaela Nadia et al
	Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11 80538 München 80538 München (DE)

(56)

References cited: :

WO-A-01/00635
WO-A-02/10124
WO-A-95/06030
WO-A-99/33792
WO-A-02/092595
US-A- 5 914 332
US-B1- 6 251 906

WO-A-02/06292
WO-A-94/05639
WO-A-95/33464
WO-A-99/33815
WO-A-03/078438
US-A- 6 150 556

"FOSAMPRENAVIR" DRUGS OF THE FUTURE, BARCELONA, ES, vol. 26, no. 3, March 2001 (2001-03), pages 224-231, XP009001334 ISSN: 0377-8282
FLYNN, DANIEL L. ET AL: "Chemical Library Purification Strategies Based on Principles of Complementary Molecular Reactivity and Molecular Recognition" JOURNAL OF THE AMERICAN CHEMICAL SOCIETY , 119(21), 4874-4881 CODEN: JACSAT; ISSN: 0002-7863, 1997, XP002109475
VAZQUEZ M L ET AL: "INHIBITORS OF HIV-1 PROTEASE CONTAINING THE NOVEL AND POTENT (R)-(HYDROXYETHYL)SULFONAMIDE ISOSTERE" JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 38, no. 4, 17 February 1995 (1995-02-17), pages 581-584, XP000999296 ISSN: 0022-2623

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).